Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-05

Study Completion Date

2023-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adult male patients brought to the emergency department as Level A trauma activations who are receiving emergency blood transfusion.

Objectives

1. Evaluate PRBC equivalents transfused in each group in the first 24 hours (Primary outcome)
2. Evaluate total transfusion in each group in the first 24 hours (Secondary Outcome) including breakdown by FFP equivalents, platelet units, and cryoprecipitate
3. Evaluate 6 hour, 24 hour, and hospital mortality (Secondary Outcome)
4. Evaluate ICU outcomes in each group

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

NCT05638581

Wounds and Injuries Shock, Hemorrhagic

RECRUITING PHASE3

Transfusion Using Stored Whole Blood

NCT02926274

Trauma Hemorrhage Coagulopathy

COMPLETED

Frozen Red Blood Cell Transfusions in Trauma Patients

NCT01038557

Blood Loss Anemia Trauma

COMPLETED NA

Early Whole Blood in Patients Requiring Transfusion After Major Trauma

NCT01227005

Trauma/Injury Problem

COMPLETED PHASE4

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

NCT04866953

Trauma Blood Transfusion Complication Death

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on the results from Cotton et al, median transfusion in the component therapy group was 6 PRBC in the first 24 hours and 4 PRBC equivalents in the whole blood group. The standard deviation (estimated from the interquartile range) was approximately 4. Thus with an expectation of alpha = 0.05 and expected power of 90% to detect a similar 2 unit difference in transfusion volume, a sample size of 190 should be sufficient; thus projected sample size of 200 should be more than adequate. Age range will be 18 years and older, and only males will be included in the study. Expected racial/ethnic distribution will be approximately 60% white, 15% black, 8% Asian, and 18% other race. No actual recruitment will be performed; rather all qualifying patients will be included. Consent waiver is being requested.

b. Objectives

1. Evaluate PRBC equivalents transfused in each group in the first 24 hours (Primary outcome)
2. Evaluate total transfusion in each group in the first 24 hours (Secondary Outcome) including breakdown by FFP equivalents, platelet units, and cryoprecipitate
3. Evaluate 6 hour, 24 hour, and hospital mortality (Secondary Outcome)
4. Evaluate ICU outcomes in each group:

1\. ICU length of stay 2. Ventilator days 3. SOFA score on day of ICU discharge 4. Presence of ARDS 5. Presence of TRALI 6. Presence of DVT/PE 7. Necessity for Dialysis 8. Necessity for Tracheostomy 9. Evaluate viscoelastic testing parameters in both groups when sent on arrival in ICU

1\. Percentage of patients with EXTEM clotting time \> 80 sec 2. Percentage of patients with EXTEM amplitude at 10 min \< 40mm and FIBTEM amplitude at 10 min ≤ 10mm 3. Percentage of patients with EXTEM amplitude at 10 min \< 40mm and FIBTEM amplitude at 10 min \> 10mm 4. Percentage of patients with maximum thrombolysis \> 15% 5. Interval analyses to be performed after 6 and 12 months with provision to continue the study out to 24 months.

1\. Stopping rule: A statistically significant difference in hospital mortality at 6 months or 12 months

1. If in favor of LTOWB, consideration of trial termination and making LTOWB the primary standard of care for all trauma patients receiving emergency transfusion except for child-bearing age females (unless Rh immunoglobulin can be administered)
2. If in favor of component therapy, consideration of trial termination and making component therapy the primary standard care for all trauma patients receiving emergency transfusion

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhagic Shock Acute Blood Loss Anemia Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Adult male patients brought to the emergency department as Level A trauma activations who are receiving emergency blood transfusion

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Titer O+ Whole Blood

Low Titer O+ Whole blood provided to Level A trauma patients

Group Type EXPERIMENTAL

Routine labs

Intervention Type COMBINATION_PRODUCT

Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.

Component Therapy

Component Therapy of O+ pRBC and FFP dispatched to trauma bay for level A traumas

Group Type ACTIVE_COMPARATOR

Routine labs

Intervention Type COMBINATION_PRODUCT

Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine labs

Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all adult male patients brought into the emergency department as LEVEL A trauma activations who are receiving emergency blood transfusions

Exclusion Criteria

* Female patients (specifically excluded due to risk of alloimmunization of Rh-negative female patients of childbearing age against Rh-positive blood)
* children
* prisoners
* all patients classified as dead upon arrival to the trauma bay

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No